Related
BioJapan

BioJapan is Asia’s premier partnering event for the international biotechnology industr

Case Study: PR euroCHEM / SME / Search for Partners in Japan

PR euroCHEM / SME / Search for Partners in Japan

Export to Japan 7: Technical Regulations - Pharmaceuticals
04
NOV
2020

What should you know when entering Pharmaceutical market in J

10:30 - 11:00
Export to Japan 9: Technical Regulations - Quasi-Drugs
20
JAN
2021

Various EU products and services began to enjoy benefits from the EU-Japan Econ

10:30 - 11:00

Quasi drugs

— Latest update: May 2024 — Quasi-drugs are medicines for the purpose of prevention of symptoms and hygiene : they have a weaker effect on the human body than medicines. Some products, such as nutritional drinks, shampoos and hair-growth products, are considered “quasi-drugs”, whereas skincare products that are less effective than “quasi-drugs” are classified as cosmetics.
Report: The Biopharmaceuticals Sector in Japan
This report aims to map out the current state of the biopharmaceuticals market in Japan.
Report: The pharmaceuticals industry in Japan
This report is designed to inform EU SMEs about the evolving structure and development trajectory of the pharmaceuticals industry in Japan.
Webinar 101: Biotech Market in Japan
19
SEP
2017

Which opportunities does the Biopharmaceutical market in Japan offer to E

10:30 - 11:30
Webinar 116: The pharmaceuticals industry in Japan
10
APR
2018

What business opportunities currently exist for European SMEs seeking to

10:30 - 11:30
Webinar 145: The Biopharmaceuticals sector in Japan
17
OCT
2019

How can I access the Japanese market as a novel biopharmaceutical product

10:30 - 11:30
Subscribe to our newsletter